What is the Return on Assets (ROA) of Sanofi this year?
The Return on Assets (ROA) of Sanofi is 0.04 undefined this year.
Sanofi ROA 2024
Sanofi ROA
0.04
Sanofi Dividend yield
Ticker
SAN.PA
ISIN
FR0000120578
WKN
920657
In 2024, Sanofi's return on assets (ROA) was 0.04, a -35.28% increase from the 0.07 ROA in the previous year.
Sanofi Aktienanalyse
What does Sanofi do?
Sanofi SA is a French company that was formed in 1973 from a merger of two French pharmaceutical and biotechnology companies. It is one of the largest players in the healthcare industry worldwide and employs over 100,000 employees. The objective of Sanofi is to improve people's lives through innovative medicines and therapies. In this regard, the company pursues a comprehensive business model that focuses on both research and development, as well as the production and distribution of medications and vaccines. The company has different divisions and product lines, which are divided into three business areas: Innovative Medicine, Consumer Healthcare, and Generic Pharmaceuticals. Innovative Medicine utilizes state-of-the-art technologies and scientific knowledge to treat the most challenging diseases. In the area of Consumer Healthcare, the company offers a wide range of over-the-counter products such as vitamins, dietary supplements, cough and cold remedies, as well as oral and dental health products. In the Generic Pharmaceuticals field, the company produces more cost-effective alternatives to expensive brand-name products, providing a variety of generic medications. Sanofi is a leading manufacturer of medications that are of great significance in various areas such as diabetes, oncology, cardiovascular diseases, and neurology. In recent years, the company has also established a strong presence in the field of vaccines. Here, Sanofi develops and produces innovative vaccines against COVID-19, influenza, and other infectious diseases. Sanofi is present in more than 170 countries and collaborates closely with physicians, research institutions, and health authorities to improve healthcare worldwide. The company conducts research and development in various disciplines and invests a significant amount each year in the development of innovative medicines and therapies. Overall, Sanofi SA is an emerging company in the pharmaceutical and healthcare sector. The portfolio of products and therapies offered by Sanofi is extensive and covers many areas of healthcare. Sanofi relies on continuous innovation and continuously works to improve healthcare and enhance the lives of people worldwide. Sanofi ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding Sanofi's Return on Assets (ROA)
Sanofi's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing Sanofi's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider Sanofi's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in Sanofi’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about Sanofi Stock
What was the ROA of Sanofi compared to the previous year?
The ROA of Sanofi has increased by -35.28% compared to the previous year.
What consequences do high ROA have for investors of Sanofi?
A high ROA is advantageous for investors of Sanofi, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in Sanofi?
A low ROA can be unfavorable for investors of Sanofi as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of Sanofi affect the company?
An increase in ROA of Sanofi can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of Sanofi impact the company?
A reduction in the ROA of Sanofi can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of Sanofi?
Some factors that can influence the ROA of Sanofi include revenue, operating costs, asset structure, and industry average.
Why is the ROA of Sanofi important for investors?
The ROA of Sanofi is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can Sanofi take to improve ROA?
To improve ROA, Sanofi can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does Sanofi pay?
Over the past 12 months, Sanofi paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sanofi is expected to pay a dividend of 3.76 EUR.
What is the dividend yield of Sanofi?
The current dividend yield of Sanofi is .
When does Sanofi pay dividends?
Sanofi pays a quarterly dividend. This is distributed in the months of June, June, June, June.
How secure is the dividend of Sanofi?
Sanofi paid dividends every year for the past 26 years.
What is the dividend of Sanofi?
For the upcoming 12 months, dividends amounting to 3.76 EUR are expected. This corresponds to a dividend yield of 4.12 %.
In which sector is Sanofi located?
Sanofi is assigned to the 'Health' sector.
Wann musste ich die Aktien von Sanofi kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Sanofi from 5/15/2024 amounting to 3.76 EUR, you needed to have the stock in your portfolio before the ex-date on 5/13/2024.
When did Sanofi pay the last dividend?
The last dividend was paid out on 5/15/2024.
What was the dividend of Sanofi in the year 2023?
In the year 2023, Sanofi distributed 3.313 EUR as dividends.
In which currency does Sanofi pay out the dividend?
The dividends of Sanofi are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Sanofi stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank
Andere Kennzahlen von Sanofi
Our stock analysis for Sanofi Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sanofi Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
